Kuno K, Yafuso M, Hakamada S, Miyachi Y, Nakashima T, Hayakawa F, Nakashima S
Jpn J Antibiot. 1985 Oct;38(10):2897-902.
Clinical evaluation of ceftizoxime suppository (CZX-S), a new antibiotic rectal suppository, was performed in 5 cases with bacterial infections in pediatric field (2 with acute bronchitis, 1 with acute tonsillitis, UTI and pertussis, respectively) and the following results were obtained; Blood levels of CZX at 10-20 minutes after administration of CZX-S at a dose of 10.0-26.3 mg/kg in 5 cases were 3.26-23.3 micrograms/ml and the urinary excretion rates within 6 hours were 15.2, 60.1, 60.2% in 3 of 5 cases measured respectively. Clinical effects were excellent in 3 and good in 2 cases. Slight elevation of GOT and GPT was observed in 1 case. No other side effects were observed. The patients' tolerability against rectal suppository was good. From the above results, we concluded that CZX-S is useful for treating the pediatric patients with various infections.
对一种新型抗生素直肠栓剂头孢唑肟栓(CZX-S)进行了临床评估,研究对象为5例儿科细菌感染患者(分别为2例急性支气管炎、1例急性扁桃体炎、1例泌尿道感染和1例百日咳),并获得了以下结果:5例患者以10.0 - 26.3 mg/kg的剂量使用CZX-S后10 - 20分钟,血液中头孢唑肟水平为3.26 - 23.3微克/毫升,在分别测定的5例中的3例中,6小时内的尿排泄率分别为15.2%、60.1%、60.2%。临床疗效3例为优,2例为良。1例患者观察到谷草转氨酶(GOT)和谷丙转氨酶(GPT)略有升高。未观察到其他副作用。患者对直肠栓剂的耐受性良好。根据上述结果,我们得出结论,CZX-S可用于治疗患有各种感染的儿科患者。